Table 5.

Overall comparison of all Core Recommendations by mean score (question 7, veterinary medicine).

Number	Core Recommendations	Mean score
43	Promote and support development of veterinary vaccines	4.4
39	Develop new approaches to improve the benefit-risk assessment of veterinary medicinal products	4.4
40	Continue to promote the responsible use of antimicrobials and their alternatives	4.4
32	Transform the regulatory framework for innovative veterinary medicines	4.4
46	Identify and enable access to the best expertise across Europe and internationally	4.4
37	Collaborate with stakeholders to modernize veterinary pharmacoepidemiology and pharmacovigilance	4.3
45	Leverage collaborations between academia and network scientists to address rapidly emerging regulatory science research questions	4.2
41	Coordinate Network activities to improve data collection on antimicrobial use in animals	4.1
42	Engage with stakeholders to minimize the risks of anti-parasitic resistance	4.1
47	Disseminate and exchange knowledge, expertise, and innovation across the network and to its stakeholders	4.0
35	Update Environmental Risk Assessments in line with the latest scientific knowledge	3.9
33	Reinforce and further embed application of the 3Rs principles	3.9
44	Develop network-led partnerships with academia to undertake fundamental research in strategic areas of regulatory science	3.9
36	Apply the latest scientific principles to the assessment of the safety of residues of veterinary medicines	3.7
34	Facilitate implementation of novel manufacturing models	3.7
38	Develop new and improved communication and engagement channels and methods to reach out to stakeholders	3.6

Overall means were calculated based on the individual scores given by participants who rated each Core Recommendation on a scale from 1 to 5: (1) not important; (2) less important; (3) moderately important; (4) important; (5) very important.